Washington Univeristy
St Louis, Missouri, 63110, United States
NCT Number: NCT05300581
Patients with a history of injection drug use are historically excluded from home outpatient parenteral antibiotic therapy programs. Recent small pilot programs have demonstrated that these patients may be safely included in home OPAT programs when they are provided with medications for opioid use disorder such as suboxone or methadone. However nothing is known about the effect of additional social support services including case management and health coach navigation on the feasibility and acceptibility of home OPAT programs for persons who inject drugs. This observational study will provide pilot data on the feasibility of such a program in anticipation of a larger scale trial.
Looking for future studies?
Notify Me18 year–100 year
All sexes
Interventional
Not applicable
St Louis, Missouri, 63110, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Observational: Patients with a history of injection opioid use will receive home OPAT while also receiving substance use disorder care including medications for opioid use disorder and multidisciplinary health coach and case management support.
Time frame: 6 weeks patient participation
Participants will be asked to self-report compliance to the recommended IV antibiotic therapy during a telephone survey performed at completion of antibiotic therapy.
Time frame: 6 weeks patient participation
Participants will have urine drug screens performed at clinic follow-up visit while on OPAT.
Time frame: 3 month chart review
Time frame: 3 month chart review
Time frame: 3 month chart review
Time frame: One year post-enrollment
Washington University School of Medicine
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07549126
Chemically-Induced Disorders, Clinical Decision Support
Guilford, Connecticut, United States
View Trial DetailsNCT05109429
Chemically-Induced Disorders, Measure Development
Baltimore, Maryland, United States
View Trial DetailsNCT05459922
Chemically-Induced Disorders, Mental Disorders
Phoenix, Arizona, United States
View Trial DetailsNCT05853289
Chemically-Induced Disorders, Mental Disorders
Baltimore, Maryland, United States
View Trial Details